期刊文献+

血浆内脂素在冠心病合并2型糖尿病患者中的表达 被引量:1

下载PDF
导出
摘要 目的探讨血浆内脂素在冠心病合并2型糖尿病患者中的表达。方法 90例经过冠状动脉造影确诊为冠心病患者(冠心病组)中,其中合并2型糖尿病患者(冠心病合并2型糖尿病组)51例,不合并2型糖尿病患者(冠心病不合并2型糖尿病组)39例;另外选择32名健康者作为对照组。检测所有入选人群的血浆内脂素的水平。结果不合并2型糖尿病组的内脂素水平明显高于对照组(P<0.01)。冠心病组各亚组间比较,合并2型糖尿病组的内脂素高于不合并2型糖尿病组(P<0.01),血浆内脂素水平随着冠状动脉病变支数的增加而升高,各亚组间的比较差异有统计学意义(P<0.01)。冠心病组血浆内脂素水平与冠状动脉病变支数呈正相关(P<0.01)。结论冠心病患者血浆内脂素水平明显高于健康者,合并2型糖尿病者血浆内脂素水平升高更明显,而且与冠状动脉病变程度密切相关。
出处 《中西医结合心脑血管病杂志》 2012年第12期1421-1422,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献7

  • 1Bessa SS, Hamdy SM, El Sheikh RG. Serum visfatin as a non- traditional biomarker of endothelial dysfunction in chronic kidney disease: An Egyptian study[J]. Eur J Intern Med, 2010, 21 (6) : 530 - 535.
  • 2Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages o{ human unstable carotid and coronary atherosclerosis:Possible role in inflammation and plaque destabilL zation[J]. Circulation, 2007,115(8) :972 - 980.
  • 3Kadoglou NP, Gkontopoulos A, Kapelouzou A, et al. Serum levels of vaspin and vis{atin in patients with coronary artery disease- Kozani study[J]. Clin Chim Acta,2011,412(l - 2): 48 - 52.
  • 4Hug C, [.odish HF. Medicine visfatin A new adipokine[J]. Sci ence,2005,307(5708) 307 - 366.
  • 5Lopoz - Bermejo A, Chico - Julrt B, Femhndez - Balsclls M, et col. Serum visfatin increases with progressive beta - cell deterioration [J]. Diabetes,2006,55(10) :2871 - 2875.
  • 6杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76
  • 7Chen MP, Chuang FM, Chang DM, et al. Elevatealplasma level of visfatin pre - B - cell colony enhancing factor in patients with type 2 diabetes mellitus[J]. Clin Endocrinol Metab, 2006,91 ( 1 ) : 295 299.

二级参考文献7

  • 1Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc,2001,60:329-339.
  • 2Hug C, Lodish HF. Visfatin: A new adipokine. Science, 2005,307:366-367.
  • 3Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science, 2005,307:426-430.
  • 4Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab, 2006,91:295-299.
  • 5Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol, 2005,185:R1-8.
  • 6Berndt J, Kloting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 2005,54:2911-2916.
  • 7Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med, 2005,6:45-50.

共引文献75

同被引文献8

  • 1Qu HY, Xiao YW, Jiang GH, et al. Effect of atorvastatin versus ro suvastatin on levels of serum lipids, inflammatory markers and adi ponectin in patients with hypercholesterolemia[J]. Pharm Res, 2009,26(4) :958 - 964.
  • 2Brunetti ND, Maulucci G, Casavecchia GP, et al. Improvement in endothelium dysfunction in diabetics treated with statins: A ran domized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg[J]. J Interv Cardiol,2007,24(6) : 1540 - 8183.
  • 3Tahara N, Kai H, Ishibashi M,et al. Simvastatin attenuates plaque inflammation:Evaluation by f[uorodeoxyglucose positron emission tomography[J]. J Am Coil Cardiol,2006,48(9) : 1825 - 1831.
  • 4Rother E,Brandl R,Baker DL,et al. Subtype selective antago- nists of lysophosphatidic acid receptors inhibit iolatelet activation triggered by the lipid core of atherosclerotie plaques [J]. Circula tion,2003,108 (6) :741 - 747.
  • 5Dahl TB, Yndestad A, Skjelland M,et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis:Possible role in inflammation and plaque dcstabili zation[J].Circulation,2007,115(8):972- 980.
  • 6王霞霞,田建会.瑞舒伐他汀与阿托伐他汀对急性冠状动脉综合征病人脂蛋白和炎症因子影响[J].青岛大学医学院学报,2009,45(3):272-273. 被引量:59
  • 7王琦,宋禾,姚霁航,周东晖,柳兢,孙小强,姚凤臣.瑞舒伐他汀对兔动脉粥样硬化斑块的抑制作用[J].山东医药,2010,50(33):25-27. 被引量:27
  • 8不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412. 被引量:2696

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部